Cobalex

Quick links to important sections

Cobalex

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cobalex

Quick Facts

Property Description
Active ingredient Hydroxocobalamin
Form Injectable Solution (Parenteral Preparation)
Pharmacological class Anti-anemic agent, Hematopoietic vitamin
General purpose Replenish Vitamin B₁₂ reserves in deficiency
Origin/Type Naturally occurring Cobalamin analogue

What Type of Medicine is Cobalex?

Cobalex is a pharmaceutical preparation that is formally classified as a prescription drug (Rx) and contains the active ingredient Hydroxocobalamin. Medically, it is categorized as an anti-anemic agent and a hematopoietic vitamin. This classification reflects its essential therapeutic role in supporting the body's natural processes for forming and maturing blood components. The product is manufactured as a sterile injectable solution for use as a parenteral preparation, distinguishing it as a form administered outside the gastrointestinal tract.

Hydroxocobalamin: Composition and Natural Origin

The composition of Cobalex features Hydroxocobalamin as the sole active ingredient, suspended in an aqueous solution necessary for injection. Hydroxocobalamin is chemically defined as a water-soluble vitamin and is regarded as a naturally occurring form of Cobalamin (Vitamin B₁₂), differentiating it from the synthetic compound, Cyanocobalamin. This essential nutrient must be supplied externally, as the human body lacks the mechanisms to synthesize it. Hydroxocobalamin's enhanced protein binding capacity can lead to a more sustained elevation of circulating vitamin B₁₂ levels following administration.

General Therapeutic Purpose of Cobalex

The general therapeutic purpose of administering Cobalex is to effectively restore the body's reserves of Cobalamin to support vital physiological processes, particularly blood and nerve function. Its primary function supports erythropoiesis stimulation—the process required for the proper maturation of red blood cells—which is critical for counteracting conditions like megaloblastic anemia. The specialized parenteral preparation ensures reliable delivery of the nutrient, which is essential for patient groups experiencing impaired intestinal malabsorption, thereby maintaining consistent blood production and neurological integrity.

What side effects are possible with Cobalex?

Possible Side Effects and Safety Information

The safety profile of Cobalex (Hydroxocobalamin) is structured by governmental regulatory agencies according to the likelihood and type of adverse reaction observed in clinical use. These documented effects are classified by frequency and the body system affected, providing a non-advisory description of the risks associated with its administration.


Frequency-Classified Adverse Reactions

The most frequent effects are generally transient and are classified in regulatory documents as Very Common (ge 1/10). These include Chromaturia (red-colored urine), which is expected and transient, Erythema (skin redness), Headache, Nausea, and a temporary Increase in Blood Pressure. Reactions such as localized pain, swelling, or irritation at the injection site are typically classified as Common.

Less frequently, Rare or Very Rare adverse events are documented, most notably Anaphylaxis and other severe hypersensitivity reactions.


Serious Reactions and Safety Constraints

Official labeling highlights the potential for Serious Adverse Reactions, including the rare occurrence of severe allergic events and reports of Acute Renal Injury linked to the formation of oxalate crystals in the urine.

Regulatory documents also detail specific safety constraints related to the drug's properties. The compound's deep red color is documented to interfere with the colorimetric determination of numerous laboratory tests, and caution regarding potential photosensitivity is included in the safety information.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile for Cobalex (Hydroxocobalamin) based on its role as a vitamin replacement agent. For its primary use, no specific signs or symptoms of overdose are known, and the active ingredient is not associated with known toxicity at replacement levels.

Documented Complications and Emergency Actions

The regulatory profile is structured to address complications arising from massive, acute exposure, which constitutes the highest documented event. Immediate medical attention is required upon observing severe manifestations, as defined in official labeling:

  • Acute Renal Failure: Complications officially documented include acute renal failure, specifically associated with acute tubular necrosis and significant renal impairment.
  • Hypersensitivity and Anaphylaxis: The possibility of serious allergic reactions, including anaphylaxis and angioneurotic edema, is officially documented as a severe outcome.

Required Monitoring and Support

No specific antidote is known for Cobalamin analogs. Management involves symptomatic and supportive treatment. Regulators mandate specific post-exposure actions, including close monitoring of renal function and blood pressure for a period following high-dose exposure. The drug's intense color may also interfere with numerous laboratory tests, a factor that must be considered during patient observation.

Therapeutic Uses of Cobalex

Cobalex is commonly used for managing conditions associated with a low level of Vitamin B₁₂ (Cobalamin), such as deficiency anemia. It is generally applied across therapeutic domains where additional symptomatic support is needed to address systemic imbalance and protect functional stability.

Therapeutic Scope

This medication helps address symptom clusters that create noticeable physiological strain, primarily targeting the severe fatigue, profound weakness, and lack of energy often associated with megaloblastic anemia. Cobalex is relevant in managing pernicious anemia, conditions following bariatric surgery, and may be part of symptomatic management for acute cyanide toxicity.

Quick Fact: Supportive Relief for Systemic Imbalance

Cobalex supports the nervous system by helping address symptoms of increased neurological or muscular activity, such as numbness and tingling (paresthesia) and difficulties with balance (ataxia), which may interfere with daily functioning. This supportive relief may assist with easing the overall symptom load associated with chronic B₁₂ depletion and supports patients during episodes of heightened discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Cobalex (Hydroxocobalamin)

The eligibility for using Cobalex is strictly defined by the population eligibility rules found in official regulatory documentation.

Absolute Contraindications

Cobalex is contraindicated and must not be used by individuals with a known hypersensitivity to the active substance, Hydroxocobalamin, or to any of the product's excipients. Furthermore, the medicine is absolutely prohibited for patients with a known sensitivity to Cobalt.

Age and Physiological Status Eligibility

Hydroxocobalamin is generally suitable for adults and children. However, caution is required when administering the injectable form to Premature Infants and Neonates due to the potential risks associated with common excipients, such as Benzyl Alcohol, and the risk of aluminum toxicity, especially with impaired renal function.

Conditional Use and Restrictions

Use is restricted for women who are pregnant or breastfeeding; it is generally not recommended unless the clinical need is clearly demonstrated by confirmed Vitamin B12 deficiency. The medicine must also be used with caution in patients with concurrent folate deficiency, as administration may mask the true underlying diagnosis. Caution is also advised in patients with impaired kidney function.

What should I know about interactions with other medicines?

The official regulatory profile for Cobalex (Hydroxocobalamin) details interactions that primarily involve substances that interfere with Vitamin B₁₂ function or alter its systemic exposure. All listed interactions and restrictions are strictly based on government-approved prescribing information.

Interactions Affecting Efficacy and Vitamin B₁₂ Levels

Several medicines are formally listed as interacting by either altering the body’s vitamin levels or impairing the therapeutic response. The antibiotic Chloramphenicol is documented to diminish the desired hematopoietic response to Hydroxocobalamin therapy.

Exposure-modifying agents, including gastric acid inhibitors like Proton Pump Inhibitors (PPIs) and H₂-receptor antagonists, along with the antidiabetic agent Metformin, are noted to reduce the body's store or absorption of Vitamin B₁₂. High doses of Folic Acid (greater than 0.1 mg daily) are documented to diminish the therapeutic effectiveness. Chronic, heavy intake of Alcohol is also documented to produce malabsorption of Vitamin B₁₂.

Pharmacodynamic Interference and Procedural Restrictions

The inhalation anesthetic Nitrous Oxide is explicitly documented to inactivate the coenzyme form of Vitamin B₁₂ by oxidation, which can heighten the risk of neurological toxicity, particularly in patients with existing, uncorrected deficiency.

Due to documented physical and chemical incompatibility, Hydroxocobalamin must not be administered simultaneously through the same intravenous line with several agents. This restriction applies to solutions containing Ascorbic Acid (Vitamin C), Sodium Thiosulfate, and Sodium Nitrite. Furthermore, the co-administration of blood products requires the use of separate intravenous lines.

Mechanism of Action

How Cobalex Works

Cobalex (Hydroxocobalamin) operates as a Coenzyme Precursor that engages two distinct metabolic pathways.


DNA Synthesis Pathway Activation and Cell Maturation

The mechanism governing the haematopoietic pathway involves the conversion of Hydroxocobalamin into the cofactor Methylcobalamin (MeCbl). This cofactor is necessary to activate the enzyme Methionine Synthase, which is vital for regenerating the functional form of Folate required for DNA synthesis. . This action facilitates cellular division and the maturation process of rapidly dividing cells in the bone marrow. This activity restores the morphological features of haematopoietic cells by correcting impaired DNA synthesis.


Lipid Metabolism and Neuronal Structure Maintenance

The mechanism affecting the Neurological System involves the conversion of Hydroxocobalamin into the second cofactor, 5-Deoxyadenosylcobalamin (AdoCbl). This cofactor activates the enzyme Methylmalonyl-CoA Mutase, which plays a crucial role in lipid and fatty acid metabolism. Sustaining this reaction ensures the metabolic clearance of Methylmalonic Acid, which supports the structural preservation of the myelin sheath surrounding nerve fibers.

Dosage and Administration Information

Cobalex is a hydroxocobalamin injection for animals and is administered according to specific procedural and dosage rules.

Official Administration Guidelines

The following information describes the standard application for this medication.

Administration Scope Requirement
Route of Administration Strictly by subcutaneous injection (under the skin).
Injection Site Administer the injection in the anterior half of the neck, just below the ear.
Dosing Schedule Dosage volumes in mL are utilized that correspond to the specific class of livestock (e.g., lambs, cows, calves, sheep).
Frequency Pattern The frequency of dosing is related to the severity of the deficiencies. For instance, in deficient areas, a repeat dose is required every two to six months, or as necessary.

Procedural Structure

The administration of this medicine is a procedural sequence that begins with selecting the appropriate dosage volume based on the animal class and ensuring all injection apparatus is sterilized. The drug is given via the subcutaneous route in the specified location. The frequency of subsequent injections is adjusted based on the animal's deficiency status, linking the schedule directly to the clinical context. Furthermore, guidelines stipulate a post-broaching use period of 60 days if the product is stored correctly below 30°C and protected from light, after which any unused portion must be discarded.

Recent Clinical Evidence

Research evidence / Overview of Studies for Cobalex

Evidence for use in Vitamin B12 Deficiency

Research concerning Hydroxocobalamin replacement includes systematic reviews, meta-analyses that compare administration methods, and observational studies. These studies examined individuals with conditions characterized by B12 depletion, such as pernicious or megaloblastic anemia, where absorption is often compromised.

Research examined the normalization of biochemical markers in the blood, such as serum B12, methylmalonic acid (MMA), and homocysteine levels, which are often indicative of a deficiency state. Research describes measurements of these biomarkers and red blood cell parameters following parenteral administration.

Evidence for use as an Antidote in Acute Cyanide Poisoning

The evidence for the use of Cobalex as an antidote in acute cyanide poisoning was studied for its application in life-threatening emergencies. The research base relies on regulatory-supporting animal studies, as well as case series and retrospective chart reviews of human patients treated in emergency settings, rather than traditional randomized controlled trials.

This research examined high-level outcomes related to acute physiological changes, including data on patient status and monitoring of physiological strain or stress, such as the reversal of cyanide-induced lactic acidosis. Studies explored populations presenting with severe toxicity, including victims of smoke inhalation. Findings indicate this use was evaluated in the context of rapid intervention.

Long-term Studies and Follow-up Intervals

Research describes the long-term use of injectable hydroxocobalamin for maintenance therapy, particularly in conditions like pernicious anemia. This data is often derived from historical observational settings and established clinical guidelines. The goal of this long-term management was studied for preventing relapse and monitoring outcomes reflecting daily functioning or activity level.

However, long-term effects are not fully established by prospective, controlled trials, meaning the current understanding largely relies on decades of clinical experience. Uncertainty remains regarding the precise schedules for long-term maintenance across different scientific guidelines.

Research Gaps and Areas of Uncertainty

Due to the serious nature of severe B12 deficiency, placebo-controlled trials are largely absent, meaning much of the evidence relies on comparisons between different forms of B12 or observational follow-up. Comparative evidence is lacking from large studies that directly compare the long-term clinical effects of injectable hydroxocobalamin against other B12 forms for preventing neurological progression.

Frequently Asked Questions (FAQ)

Common questions about Cobalex (FAQ)


Q: Is Cobalex the same thing as a regular vitamin B supplement?

A: Cobalex is formally classified as a prescription drug (Rx) and is prepared as an injectable solution (a parenteral preparation). While it contains Hydroxocobalamin, which is a form of Vitamin B₁₂, its specialized form and regulatory classification differentiate it from a standard oral vitamin supplement.


Q: Why do doctors prescribe Cobalex instead of other similar treatments?

A: The specialized injectable preparation is primarily described for use in patients who experience impaired intestinal malabsorption, as oral administration may not achieve reliable absorption in these cases. Furthermore, research indicates that the active ingredient's enhanced protein binding can lead to a more sustained elevation of circulating Vitamin B₁₂ levels in the body.


Q: What is the main difference between Cobalex and [Similar Drug X]?

A: Official descriptions note that the active ingredient, Hydroxocobalamin, is a naturally occurring form of Vitamin B₁₂, which differs from the synthetic form, Cyanocobalamin. Research has noted that Hydroxocobalamin can provide a more sustained level of the vitamin following administration.


Q: Can Cobalex cause any long-term or serious health problems?

A: Official documents list Serious Adverse Reactions, including rare occurrences of severe allergic events and reports of Acute Renal Injury. While the active ingredient has been used for long-term maintenance based on decades of clinical experience, the long-term effects are not fully established by prospective, controlled clinical trials, meaning understanding relies heavily on clinical experience.


Q: What should I do if I forget to take my dose of Cobalex?

A: If an injection appointment is missed, safety information advises against attempting to take extra doses or adjusting the schedule without first contacting a healthcare professional. You should contact the dispensing nurse or doctor to reschedule the appointment and receive instruction on the next dose.


Q: Does Cobalex interact with common over-the-counter pain relievers like ibuprofen or aspirin?

A: According to official interaction documents, common over-the-counter pain relievers like ibuprofen or aspirin are not specifically listed as interacting agents that affect the efficacy or safety of Cobalex.


Q: How long does it typically take for Cobalex to start working or for me to feel a difference?

A: Treatment response is monitored by medical professionals by examining the normalization of biochemical markers in the blood. They also monitor the improvement of deficiency symptoms, such as tiredness and lack of energy. The timing of these improvements is specific to the individual's clinical context and requires professional monitoring.


Q: Can older adults or elderly patients take Cobalex?

A: Regulatory documents list no specific restrictions or contraindications solely for the older or elderly adult population; its general suitability is for 'adults and children' but always requires professional assessment.


Q: What does 'contraindication' mean in relation to Cobalex?

A: A contraindication is a medical term used in regulatory documents to describe a specific situation or condition where a medicine should not be used because it could potentially cause harm. For Cobalex, absolute contraindications include known hypersensitivity to the drug or sensitivity to Cobalt.


Q: What are the signs of an overdose with Cobalex?

A: Safety information instructs that concerns about overdose require contacting a poison control center or seeking immediate medical attention. Regulatory profiles primarily focus on managing the most frequent and rare documented adverse reactions.


Q: Can Cobalex cause weight gain or weight loss?

A: Official adverse event documents list unusual weight gain or loss as a reaction where the incidence is not precisely known. It is noted that research does not support the idea that Vitamin B₁₂ injections directly cause weight loss.


Q: Does Cobalex help with low energy or fatigue?

A: The general therapeutic purpose is to restore B₁₂ reserves, which supports the body's processes for managing conditions like megaloblastic anemia. Improvement in symptoms of deficiency, such as tiredness and lack of energy, is a factor monitored by medical professionals to see how well the treatment is working.


Q: Does Cobalex have different uses in other countries compared to mine?

A: The active ingredient, Hydroxocobalamin, has a dual recognized therapeutic purpose globally. It is used for Vitamin B₁₂ replacement in deficiency and, at different high concentrations, is approved as an antidote for acute cyanide poisoning. The specific use approved in any country is determined by the local regulatory authorization bodies.


Q: What is the difference between an 'adverse reaction' and a 'side effect' for Cobalex?

A: Both terms describe unwanted effects that can occur when taking a medicine. In common use, a side effect often describes an expected or common effect, such as the transient red-colored urine. An adverse reaction is a broader term for any unwanted or unexpected negative response to the medicine.


Q: Does taking Cobalex require any special diet changes?

A: The primary substance mentioned in official interaction documents related to intake is the chronic, heavy intake of alcohol, which is documented to reduce the body's absorption of Vitamin B₁₂. No specific changes to a patient's general diet are prescribed in the documents.


Q: How does my body process Cobalex?

A: Research describes that the active ingredient's enhanced protein binding capacity can lead to a more sustained presence of circulating B₁₂ levels following administration. Any excess of the vitamin that is not used by the body is excreted through the urine, which is why the urine may become red-colored.


Q: Is there any information on how Cobalex works in people with diabetes?

A: One specific interaction documented in regulatory profiles related to common diabetes treatment is that the antidiabetic drug Metformin is noted to reduce the body's store or absorption of Vitamin B₁₂.


Q: Can Cobalex be taken with supplements like iron or magnesium?

A: Official documents specifically describe potential interference with high doses of Folic Acid and documented incompatibility if administered through the same IV line as solutions containing Ascorbic Acid (Vitamin C). Information about other mineral supplements, such as iron or magnesium, is not specifically detailed in the regulatory interaction documents.


Q: Why do official documents describe Cobalex's purpose the way they do?

A: Official documents utilize descriptive, neutral language to focus on the active ingredient's role as a Vitamin B₁₂ replacement agent. This practice ensures that information remains factual and avoids making guarantees or promising specific outcome claims about the drug's effects.


Q: Do studies suggest any specific patient groups benefit more from Cobalex?

A: Research examined individuals with conditions characterized by Vitamin B₁₂ depletion, such as megaloblastic anemia and individuals experiencing impaired intestinal malabsorption. Additionally, its high-dose use as an antidote was studied for life-threatening emergencies like acute cyanide poisoning.


Q: Does Cobalex interact with blood thinners like warfarin?

A: According to official documents, common blood thinning medications like warfarin (an anticoagulant) are not specifically listed as interacting agents that affect the efficacy or safety of Cobalex.


Q: What is the standard non-directive information about the proper use conditions for Cobalex?

A: For human use, the medicine is typically administered via intramuscular injection (into a muscle) or deeply subcutaneously (under the skin). The required frequency of administration is generally related to the severity of the deficiencies being addressed and is determined by a healthcare professional.


Q: Does Cobalex have any known interactions with herbal supplements?

A: Official safety resources state that there is not enough information available to confirm that all herbal remedies, complementary medicines, and supplements are safe to take concurrently with the medicine. Official safety information notes that individuals should inform their healthcare professional of all supplements being used.


Q: Can Cobalex be used in patients with liver problems?

A: Official safety warnings indicate that individuals should inform their healthcare professional if they have a history of liver disease prior to receiving the medicine. This is part of the precautionary information required before administration.


Q: Are there any differences in effectiveness between the various formulations of Cobalex?

A: Research describes a lack of comparative evidence from large studies that directly compare the long-term clinical effects of the injectable active ingredient against other forms of Vitamin B₁₂, such as oral forms. Official documents do not typically contain comparative claims between different injectable formulations of the same drug.


Q: What does the term 'pharmacovigilance' mean for a drug like Cobalex?

A: Pharmacovigilance is the medical science and activity relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems. The safety profile and side effect reports for Cobalex are part of this important ongoing regulatory monitoring.


Q: Has Cobalex been studied in patients with chronic pain conditions?

A: Research and systematic reviews have explored the role of Vitamin B₁₂ compounds in conditions related to pain, including low back pain and peripheral neuropathic pain. This research theme is separate from the drug's primary use for treating Vitamin B₁₂ deficiency.

How should Cobalex be stored and disposed of?

Cobalex (Hydroxocobalamin injection) must be stored according to strict regulatory requirements to maintain its stability.

Official Storage Conditions

Constraint Requirement
Temperature Store below 25 C (or 30 C depending on formulation).
Protection Protect from light and Do not freeze the solution.
Packaging Store in the original package to ensure light protection.
Safety Keep this medicine out of the sight and reach of children.

Disposal and Handling

The medicine is for single use only, and any unused content must be immediately discarded. Do not dispose of expired or unused medication via wastewater or household waste. Instead, return it to a pharmacist or use a designated drug take-back program for safe and environmentally responsible disposal. Used syringes and needles must be placed into a designated Sharps container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cobalex found in:

A-Z Index: